Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
BigOmics Analytics is a life-science software company spun out of Switzerland’s Institute of Oncology Research. Its core product, Omics Playground, is designed for biologists and bioinformaticians to interactively visualize and analyze omics data. The platform covers RNA-Seq and proteomics. Rather than being a general-purpose BI tool, it is positioned as a specialized analytics SaaS for transcriptomics, proteomics, and multi-omics exploration.
Based on publicly available information, Omics Playground offers 18+ analysis modules and 150+ interactive charts, and can connect with 6000+ public datasets, 50,000+ gene sets and pathways, and related databases covering 30,000+ drug expression profiles. It supports bulk-RNA seq, scRNA-seq, mRNA microarray, and LC MS/MS proteomics; ChIP-seq, ATAC-seq, and methyl-seq are not directly supported by the platform at this stage. Its main value is turning workflows that traditionally depend on scripts and repeated figure generation by bioinformatics staff into a clickable exploration experience for researchers.
Pricing is not public. The industry editions—Pro, Enterprise, and Ultimate—all require contacting sales; the academic editions include Trial, Individual, and Teams. The Trial has no clearly stated expiration date, but is limited to 1 user, 3 comparisons, 4 datasets, 4 compute credits, and 20 samples/dataset. For team workflows, the platform supports interactive data sharing, while the Enterprise and Ultimate editions provide a shared teams folder and optional SSO, custom development, data interpretation, and private cloud deployment. Security disclosures are relatively specific: AES-256 encryption at rest, TLS 1.2+ in transit, with keys managed by AWS KMS. Dedicated servers and other enhanced security layers can also be provided on request.
Its strengths are a strong vertical focus, a rich set of analysis modules, tight integration with public databases, and connectivity with platforms such as Seqera and DNAnexus. It is well suited for pharmaceutical companies, biotech firms, and academic labs that need to interpret RNA-Seq or proteomics data. The drawbacks are opaque pricing, many enterprise features being priced on request, and no visible information about an API, Chinese localization, or local payment options in China. If a team primarily analyzes sequencing data types that are not supported, it will still need to build its own workflows or use other bioinformatics platforms alongside it.
The website does not provide information on China-based nodes, ICP filing, RMB payments, or Chinese-language support, so access from China can only be rated as unknown. Domestic institutions handling sensitive biomedical data should pay particular attention to cross-border data transfer, cloud region selection, compliance review, and procurement/payment methods. Alternatives may include the DNAnexus and Seqera ecosystems, or a combination of domestic sequencing/bioinformatics service providers with self-built R/Bioconductor or Galaxy workflows.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on bigomics.ch official site.
bigomics.ch is an Switzerland SaaS provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach bigomics.ch directly.